SAN DIEGO--(BUSINESS WIRE)--Vascular BioSciences announced today that it has secured a worldwide exclusive license to intellectual property from Burnham Institute for Medical Research relating to work done by Erkki Ruoslahti M.D Ph.D., and Masanobu Komatsu, Ph.D. on their discovery of the role of the intracellular protein R-Ras in neointimal hyperplasia, angiogenesis and vascular proliferation. Drs. Komatsu and Ruoslahti found that R-Ras exerts a strong inhibitory effect on mitotic and invasive activities of activated endothelial cells and vascular smooth muscle cells, and promotes quiescence of these cells.
